Beyond the Save
  • Home
  • Find Help
  • Events
  • Community Efforts
  • Toolkit
  • Data
  • MAT
  • MHFA
  • Newsletters
  • Contact
  • Commercials
  • More
    • Home
    • Find Help
    • Events
    • Community Efforts
    • Toolkit
    • Data
    • MAT
    • MHFA
    • Newsletters
    • Contact
    • Commercials
Beyond the Save
  • Home
  • Find Help
  • Events
  • Community Efforts
  • Toolkit
  • Data
  • MAT
  • MHFA
  • Newsletters
  • Contact
  • Commercials

medication assisted treatment

Upper Peninsula's Managed Care Clinical Specialist

Melissa DeMars, LPC works with NorthCare Network and University of Michigan to help providers become waivered for MAT. She is available for questions at MDeMarse@northcarenetwork.org or 906-869-0039.

Thursdays @ 8pm -9:30p EST: MAT Advocacy Meeting

National U.S. MAT Advocacy Meetings with the National Alliance for Medication Assisted (NAMA) Recovery.

 https://zoom.us/j/427950815

Learn More Here

Clinical Info/About MAT

MAT is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to treating addiction.


MAT is primarily used for the treatment of addiction to opioids such as heroin and prescription pain relievers that contain opiates. The prescribed medication operates to normalize brain chemistry, block the euphoric effects of alcohol and opioids, relieve physiological cravings, and normalize body functions without the negative effects of the abused drug.  Medications used in MAT are approved by the Food and Drug Administration (FDA), and MAT programs are clinically driven and tailored to meet each patient’s needs.  

Need in the UP

Most of the Upper Peninsula is designated as a "Health Professional Shortage Area" and experiences shortages in specialists and mental/behavioral health care. MAT has not been widely utilized in the UP, and there is still stigma around this practice by professionals and lay people. 

How to Get Credentialed

 To receive a waiver to practice opioid dependency treatment with approved buprenorphine medications, a practitioner must notify the SAMHSA Center for Substance Abuse Treatment (CSAT) of their intent to practice this form of medication-assisted treatment (MAT). The notification of intent must be submitted to CSAT before the initial dispensing or prescribing of opioid treatment. Qualifying practitioners can treat up to 100 patients using buprenorphine for the treatment of opioid use disorder (OUD) in the first year if they  meet certain requirements. Find the waiver application here. 

Downloads

MAT Models for OUD in Primary Care Settings (pdf)

Download

Copyright © 2020 Beyond the Save - All Rights Reserved.

Powered by GoDaddy Website Builder

  • Commercials

Support for Healthier Births

If you are pregnant and struggling with opioid use, talk to your doctor right away. Addiction to opioids is a disease, and you and your baby both deserve medical care for a healthier start.

Learn more

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept